A Phase 1/2 Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma in the First Salvage Setting: Interim Results LaCasce, A., Sawas, A., Bociek, R., Ansell, S., Vose, J., O'Meara, M., Advani, R. ELSEVIER SCIENCE INC. 2014: S161

View details for DOI 10.1016/j.bbmt.2013.12.257

View details for Web of Science ID 000331155400235